Stockscreener 앱 받기
2.42
3.97%
-0.10
Yd Bio Ltd 주식(YDES)의 최신 뉴스
BRZHR Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
YD Bio Ord Shs (YDES) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
YD Bio Ord Shs (YDES) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
YD Bio Ord Shs (YDES) Institutional Confidence - TradingKey
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
YD Bio Ord Shs (YDES) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
YD Bio Ord Shs (YDES) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
YD Bio Ord Shs (YDES) Valuation: PE, PB & Fair Value Analysis - TradingKey
Morning Market Movers: SLBT, SCLX, TDIC, CRE See Big Swings - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] YD Bio Ltd SEC Filing - Stock Titan
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - Yahoo Finance
YD Bio Stock Is Falling Again: The SEC Filing Behind the Slide - Bez Kabli
iGan Partners Invests in Adenocyte Ltd to Advance the Early Detection of Pancreatic Cancer - Yahoo Finance
YD Bio (NASDAQ: YDES) prospectus lists 58.6M resale shares, 11.4M exercisable - Stock Titan
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX) - Yahoo Finance
Registrar Corp and U.S. Commercial Service Strengthen Partnership to Support Australian Companies Expanding into the U.S. - Yahoo Finance
Yourgene Health Launches Insight DPYD Assay - Yahoo Finance
Affiliated (MGRE) Steady at $$24.02 — Awaiting Next Catalyst 2026-05-13Rip Sell Trade - The Legal Advocate
YD Bio Limited Ordinary Shares Stock Forecast Summary - Meyka
Autoliv posts upbeat Q1 results, joins United Airlines, Royal Caribbean Cruises and other big stocks moving higher on Friday - MSN
YD Bio Limited Reports Full Year 2025 Financial Results - ChartMill
YD Bio Limited Reports Financial Results for Full Year 2025, Achieves 17% Revenue Growth and Strategic Advances in Healthcare Innovations - Quiver Quantitative
YD Bio 2025 Loss/Shr 12c >YDES - Moomoo
After a $13.9M equity raise, YD Bio enters 2026 with $6M cash - Stock Titan
Going concern warning tops YD Bio (NASDAQ: YDES) 20-F risk disclosures - Stock Titan
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026 - Yahoo Finance
New LowStock ScreenerSnapshot - Finviz
Immuneering Corp (IMRX) Stock Price, Quote, News & History - Benzinga
CMMB (Chemomab Therapeutics Ltd. American Depositary Share) posts narrower Q4 2025 loss than estimates, while shares dip modestly.Community Trade Ideas - Xã Thanh Hà
What is happening with Elbit Systems (ESLT) stock today (Smart Money Active) 2026-04-20High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai
[Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Shao Ta Lu Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday - Sahm
Man Edmund Hen Net Worth (2026) - GuruFocus
Bo Xiang Zhang Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Movi - Benzinga
GFL ENVIRONMENTAL INC. (GFL) - MSN
How does macroeconomics affect YD Bio (YDES) Stock | Price at $5.97, Down 4.57%Portfolio Management - newser.com
Is YD Bio (YDESW) Stock slowing down | Price at $0.58, Down 10.08%Market Hype Signals - Newser
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness - Yahoo Finance
YDES Technical Analysis & Stock Price Forecast - Intellectia AI
YDES SEC FilingsYD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
CRVL Stock Analysis: CorVel Corp. notches 1.6 pct daily gain near 54 key support - The Legal Advocate
YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan
Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan
YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan
Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan
YD Bio launches telehealth platform for cancer detection By Investing.com - Investing.com South Africa
YD Bio launches telehealth platform for cancer detection - Investing.com
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - The Manila Times
Yd Bio Limited and Eg Biomed Co., Ltd. Launch Nationwide Telehealth Platform - marketscreener.com
Cancer test platform goes live in 44 states, D.C. and Guam - Stock Titan
YD Bio (YDES) director files Form 3 with no share activity - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
[Form 3] YD Bio Ltd Initial Statement of Beneficial Ownership - Stock Titan
[Form 3] YD Bio Ltd Initial Statement o... - Stock Titan
0.74%
1.44%
자본화:
|
볼륨(24시간):